252 related articles for article (PubMed ID: 11251168)
1. Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy.
Chen B; Zupkó I; de Witte PA
Int J Oncol; 2001 Apr; 18(4):737-42. PubMed ID: 11251168
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
Du HY; Bay BH; Olivo M
Int J Oncol; 2003 May; 22(5):1019-24. PubMed ID: 12684667
[TBL] [Abstract][Full Text] [Related]
3. Comparison of hexamethylhypericin and tetrabromohypericin to hypericin for their in vivo efficacy as PDT tools.
Delaey E; Zupko I; Chen B; Derycke A; van Laar F; De Vos D; De Witte P
Int J Oncol; 2003 Aug; 23(2):519-24. PubMed ID: 12851704
[TBL] [Abstract][Full Text] [Related]
4. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
[TBL] [Abstract][Full Text] [Related]
5. Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hyperthermia.
Chen B; Roskams T; de Witte PA
Lasers Surg Med; 2002; 31(3):158-63. PubMed ID: 12224088
[TBL] [Abstract][Full Text] [Related]
6. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA
Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects.
Chin W; Lau W; Cheng C; Olivo M
Int J Oncol; 2004 Sep; 25(3):623-9. PubMed ID: 15289863
[TBL] [Abstract][Full Text] [Related]
8. Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT.
Thong PS; Watt F; Ren MQ; Tan PH; Soo KC; Olivo M
J Photochem Photobiol B; 2006 Jan; 82(1):1-8. PubMed ID: 16203156
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model.
Chen B; Roskams T; Xu Y; Agostinis P; de Witte PA
Int J Cancer; 2002 Mar; 98(2):284-90. PubMed ID: 11857421
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model.
Chen B; Xu Y; Roskams T; Delaey E; Agostinis P; Vandenheede JR; de Witte P
Int J Cancer; 2001 Jul; 93(2):275-82. PubMed ID: 11410877
[TBL] [Abstract][Full Text] [Related]
11. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes.
Maugain E; Sasnouski S; Zorin V; Merlin JL; Guillemin F; Bezdetnaya L
Oncol Rep; 2004 Sep; 12(3):639-45. PubMed ID: 15289849
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy of transitional cell carcinoma multicellular tumor spheroids with hypericin.
Kamuhabwa AA; Huygens A; De Witte PA
Int J Oncol; 2003 Nov; 23(5):1445-50. PubMed ID: 14532989
[TBL] [Abstract][Full Text] [Related]
13. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL
Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the photodynamic effect of hypericin in human bladder transitional cell carcinoma spheroids by the use of the oxygen carrier, perfluorodecalin.
Kamuhabwa AR; Huygens A; Roskams T; De Witte PA
Int J Oncol; 2006 Mar; 28(3):775-80. PubMed ID: 16465384
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
16. Enhancing the photodynamic effect of hypericin in tumour spheroids by fractionated light delivery in combination with hyperoxygenation.
Huygens A; Kamuhabwa AR; Van Laethem A; Roskams T; Van Cleynenbreugel B; Van Poppel H; Agostinis P; De Witte PA
Int J Oncol; 2005 Jun; 26(6):1691-7. PubMed ID: 15870887
[TBL] [Abstract][Full Text] [Related]
17. Hypericin as a potential phototherapeutic agent in superficial transitional cell carcinoma of the bladder.
Kamuhabwa A; Agostinis P; Ahmed B; Landuyt W; van Cleynenbreugel B; van Poppel H; de Witte P
Photochem Photobiol Sci; 2004 Aug; 3(8):772-80. PubMed ID: 15295634
[TBL] [Abstract][Full Text] [Related]
18. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
Zhou Q; Olivo M; Lye KY; Moore S; Sharma A; Chowbay B
Cancer Chemother Pharmacol; 2005 Dec; 56(6):569-77. PubMed ID: 16001166
[TBL] [Abstract][Full Text] [Related]
19. Photoactivation of hypericin down-regulates glutathione S-transferase activity in nasopharyngeal cancer cells.
Du HY; Olivo M; Tan BK; Bay BH
Cancer Lett; 2004 Apr; 207(2):175-81. PubMed ID: 15072826
[TBL] [Abstract][Full Text] [Related]
20. Low dose hypericin-PDT induces complete tumor regression in BALB/c mice bearing CT26 colon carcinoma.
Sanovic R; Verwanger T; Hartl A; Krammer B
Photodiagnosis Photodyn Ther; 2011 Dec; 8(4):291-6. PubMed ID: 22122915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]